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Abstract
Background: The Pontifical Academy for Life (PAV) is an academic institution of the Holy See (Vatican),
which aims to develop and promote Catholic teachings on questions of biomedical ethics. Palliative care (PC)
experts from around the world professing different faiths were invited by the PAV to develop strategic rec-
ommendations for the global development of PC (‘‘PAL-LIFE group’’).
Design: Thirteen experts in PC advocacy participated in an online Delphi process. In four iterative rounds,
participants were asked to identify the most significant stakeholder groups and then propose for each, strategic
recommendations to advance PC. Each round incorporated the feedback from previous rounds until consensus
was achieved on the most important recommendations. In a last step, the ad hoc group was asked to rank the
stakeholders’ groups by order of importance on a 13-point scale and to propose suggestions for implementation. A
cluster analysis provided a classification of the stakeholders in different levels of importance for PC development.
Results: Thirteen stakeholder groups and 43 recommendations resulted from the first round, and, of those, 13
recommendations were chosen as the most important (1 for each stakeholder group). Five groups had higher
scores. The recommendation chosen for these top 5 groups were as follows: (1) Policy makers: Ensure universal
access to PC; (2) Academia: Offer mandatory PC courses to undergraduates; (3) Healthcare workers: PC
professionals should receive adequate certification; (4) Hospitals and healthcare centers: Every healthcare
center should ensure access to PC medicines; and (5) PC associations: National Associations should be effective
advocates and work with their governments in the process of implementing international policy framework. A
recommendation for each of the remaining eight groups is also presented.
Discussion: This white paper represents a position statement of the PAV developed through a consensus
process in regard to advocacy strategies for the advancement of PC in the world.
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Background
Every year, over 25.5 million people die with serioushealth-related suffering (SHS) associated with life-
limiting and life-threatening conditions. An additional 35
million live with these conditions and SHS.1 Yet the vast
majority of the world does not have access to adequate
treatment and care and social support.
Palliative care (PC) helps relieve SHS by providing
physical, psychosocial, and spiritual care to patients and their
families. PC relieves ‘‘total pain’’ by shifting the often overly
technical modern medical model to a holistic person-centered
model of care.2
Estimates of unmet PC needs worldwide are around 26.8
million per year.3 Other data suggest an even greater need of
up to 40 million people per year,4 with estimates reaching 61
million people around the globe suffering from SHS.1 Var-
ious additional studies have shown a deficit of PC demand to
PC supply,5–9 highlighting a lack of access to PC as a major
global health inequity issue.10,11
There has been a rising burden of noncommunicable dis-
eases (NCDs) worldwide, and globally, NCDs cause 70% of
all deaths12 and generate 93% of adult PC need, and nearly
80% of the global PC need is in low-to-middle income
countries.3,5 Furthermore, the global population is aging, and
this, partnered with the increased prevalence of NCDs and the
persistence of other debilitating chronic and infectious dis-
eases, reflects an alarming increase in need for PC provision
at the global scale.4 In fact, studies estimate that by 2040, the
proportion of people worldwide in need of PC will increase
from 25% to 47%.13
This growing need is recognized by global health organi-
zations; the World Health Organization (WHO) recently
approved the 13th General Program of Work recognizing the
‘‘limited availability of [PC] services in much of the world
and the great avoidable suffering for millions of patients and
their families’’4,14 and concluded with several recommen-
dations for further PC development and support for global PC
advocacy campaigns. Although research has shown that PC
has steadily grown at the global level, the demand far out-
strips supply, and this growth has been very uneven, with
some countries having progressed very little over the past
decade.4–9
The Catholic Church’s appreciation for the PC as an ap-
proach to take care of the vulnerable is evident in its cate-
chism, which includes the following statement ‘‘[Palliative
care] represents a special form of disinterested charity, and as
such, should be encouraged’’ (Catechism of the Catholic
Church, n. 2279). Recently, Pope Francis shared with health
professionals meaningful words on PC: ‘‘I encourage pro-
fessionals and students to specialize in this type of assistance
which is no less valuable for the fact that it is not life-saving.
[PC] accomplishes something equally important: it values the
person.’’15
The Pontifical Academy for Life (PAV) is an academic
institution of the Holy See (Vatican) dedicated to the pro-
motion of human life, and, among other specific topics, the
study issues in medical ethics. In 2017, the PAV launched an
international project called ‘‘PAL-LIFE: An International
Advisory Working Group on diffusion and development of
palliative care in the world’’ to advise on how the Catholic
Church could assist in continued PC development at the
global level.16 This white paper represents a position state-
ment of the PAV regarding PC, intended to be used for ad-
vocacy with local governments, healthcare organizations,
leaders on the ground, and faith-based communities.
Design
A process was developed to generate consensus among 13
PC experts on key recommendations for major stakeholders’
groups, including ranking both the recommendations and the
stakeholders’ groups by importance, as well as providing
suggestions for implementation.
The study was submitted and approved by the Clinical
Research Ethics Committee of the University of Navarra.
Selection of experts and definition of the process
The expert group was selected considering and balancing
diverse geographical regions and professional backgrounds.
Members included clinicians, ethicists, and health adminis-
trators working in academic centers or international and re-
gional PC organizations and professing different faiths. The
PAV initially chose three experts in PC advocacy with global
expertise in PC development. In a second step, additional
experts were added to the group through a snowball process
of recommendations by at least 2 peer experts reaching a total
of 13 persons considered to be experts in PC advocacy (‘‘ad
hoc group’’). Two additional experts were invited in the last
stage of the process based on the suggestion of several
members of the group. Table 1 shows the members of the ad
hoc group.
An initial face-to-face meeting was conducted at the venue
of the PAV in Rome, in March 2017. The purpose of the
meeting was to define the strategy and methodology for
identification of the key recommendations to be determined
by the ad hoc group. It was outlined as the project for a draft
of a position statement (‘‘white paper’’) on PC advocacy
containing recommendations for health policy planning and
providing guidance to different stakeholder groups on how to
advance the development of PC in countries and regions.
For the purposes of this project, the ad hoc group used the
WHO definition of PC. The group also adopted the WHO
public health strategy framework for PC.17
Identification of stakeholder groups
In Round 1, experts of the ad hoc group were invited by e-
mail to identify the most relevant stakeholder groups to
which the recommendations would be directed to. These
stakeholder groups were identified based on their key roles in
their ability to promote PC development at national or re-
gional levels in healthcare and/or society.
From the initial list, through a Delphi consensus process,
members of the ad hoc group suggested new stakeholder
groups or modified ones already in the list, resulting in a final
list of 13 groups. Based on the field of expertise, each expert
was assigned to a specific stakeholder group. Table 2 shows
the stakeholder groups agreed upon by the ad hoc group.
Consensus process for the recommendations
In Round 2, each member was contacted by e-mail and
requested to provide two to three recommendations for his/
her corresponding stakeholder group. Each recommendation
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was accompanied by a statement, including rationale for the
proposal, up to a maximum of 200 words. Recommenda-
tions were built upon the previous work and experience of
the experts within their own or several other institutions to
ensure best possible recommendations per stakeholder
group.
In Round 3, all the recommendations were shared with the
entire ad hoc group through an online survey tool (https://
es.surveymonkey.com), and each member of the ad hoc
group was asked to rank each recommendation on a Likert
scale from 1 to 5 (1 being ‘‘not important at all’’ and 5 being
‘‘extremely important’’). The average number of points for
each recommendation was calculated.
The results were preliminarily presented in a PC conference
organized by the PAV in Rome in March 2018 and, subse-
quently, discussed by the ad hoc group in a new face-to-face
meeting with a subset of the experts. During this meeting, a
thorough review of the recommendations and suggestions for
implementation was conducted to improve wording.
In Round 4, 12members of the ad hoc group reviewed their
previous ratings and conducted another round of rankings of
the stakeholder groups based on their perceived impor-
tance for PC development. Using a 13-point scale, points
were assigned to each, according to the ranking given by
each member [range: 12 (worst = 1 point per expert) to 156
(best = 13 points per expert)]. An exploratory K-means
cluster analysis provided a classification of the stakeholders
in different levels of importance for PC development. As final
step in this Round 4, members of the ad hoc group were asked
to provide suggestions for implementation for each of the
recommendations.
PAV endorsement of the recommendations
and presentation of outcomes
The resulting recommendations from each stakeholder
group were revised and agreed upon, then endorsed by the
Board of Directors of the PAV. The endorsement will be
announced during the plenary session of the annual meeting
of the PAV (June 2018) as the official position of the
Academy and as the recommendations of PAL-LIFE.
In this article we present the five highest ranked recom-
mendations (‘‘first-line’’) with concrete suggestions for im-
plementation. The additional eight recommendations for the
remaining stakeholders’ groups are presented as second-line
interventions. All the recommendations are accompanied by a
description, rationale, and bibliographic references. Additional
Table 2. Ranking of Stakeholder Groups
Stakeholder group Points
Group
K-mean
Policymakers 122 103.4
Universities (academia) 111
Healthcare workers 103
Hospitals and healthcare centers 92
Palliative care associations 89
International organizations 71 52.4
Mass media 69
Philanthropic organizations and charities 62
Pharmaceutical authorities 59
Patients and patient groups 53
Spiritual care professionals 50
Associations other than palliative care 29
Pharmacists 26
Scores on relative importance (range 1–156) and K-means for
cluster analysis.
Table 1. Members of the PAL-LIFE Ad Hoc Group
Name Title/Institution City Country
Alsirafy, Samy Head of the Palliative Medicine Unit, Kasr Al-Ainy School
of Medicine, Cairo University
Cairo Egypt
Bruera, Eduardo Chair, Department of Palliative Medicine and Supportive
Care, UT MD Anderson Cancer Center
Houston United States
Callaway, Mary V. Board of Directors, IAHPC Houston United States
Centeno, Carlos Director, ATLANTES Research Group, University of
Navarra
Pamplona Spain
De Lima, Liliana Executive Director, International Association for Hospice
and Palliative Care (IAHPC)
Houston United States
Foley, Kathleen M. Attending Neurologist Emeritus, Memorial Sloan Kettering
Cancer Center
New York United States
Luyirika, Emmanuel Executive Director, African Palliative Care Association
(APCA)
Kampala Uganda
Mosoiu, Daniela Director, Casa Sperantei, Assoc Prof. Transylvania
University
Brasov Romania
Pettus, Katherine Advocacy Officer, IAHPC Houston United States
Puchalski, Christina Director, The George Washington University’s Institute for
Spirituality and Health (GWish) Professor of Medicine
GWU
Washington United States
Rajagopal, M.R. Director Pallium India, WHO Collaborating Centre for
Training and Policy on Access to Pain Relief
Trivandrum India
Sitte, Thomas CEO Deutsche PalliativStiftung Fulda Germany
Yong, Jin-Sun Director, The Catholic University of Korea (CUK), WHO
Collaborating Centre for Training in Hospice and
Palliative Care. Professor of Nursing, CUK
Seoul South Korea
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recommendations discussed by the group, but not ranked
within the highest scores for importance, are included in a
report on the PAV website (www.academyforlife.va).
Results
Thirteen stakeholder groups and 43 recommendations re-
sulted from the first round, and of those, 13 recommendations
were chosen as the most important (1 for each stakeholder
group) and are presented in this study. These, plus the addi-
tional 30 recommendations are available in the PAV website.
Table 2 indicates the stakeholder groups and the total
scores each received through the ranking (range 1–156). The
K-means cluster analysis confirmed the existence of two
levels in the ranking of the stakeholders’ groups as follows:
five groups had higher scores (closer to K-mean 103.4) and
nine stakeholder groups lower ones (closer to K-mean 52.4).
First-line stakeholder groups for advocacy are (1) policy
makers (in all units of government); (2) academia (univer-
sities and colleges); (3) healthcare workers; (4) hospitals and
healthcare centers; and (5) PC professional associations. The
recommendations for first-line stakeholders are included in
Table 3 along with suggestions for their implementation.
Second-line stakeholder groups (Table 4) are (6) interna-
tional organizations; (7) mass media; (8) philanthropic or-
ganizations and charities; (9) pharmaceutical authorities; (10)
patients and patient groups; (11) spiritual care profession-
als; (12) non-PC professional associations and societies; and
(13) pharmacists. The recommendations can be seen in
Table 4.
Reflections for the advocacy of PC to first-line
stakeholders’ groups
Policy makers. Patients with chronic progressive dis-
eases, such as cancer, congestive heart failure, chronic ob-
structive pulmonary disease, and HIV/AIDS, develop severe
physical, psychosocial, and spiritual symptoms before
death.1,18 There is strong evidence that PC is beneficial in
reducing much of this suffering in patients, as well as psy-
chosocial and spiritual or existential distress in families.19
There is strong evidence that these benefits are accompa-
nied by a reduction in the total cost of care.20 Cost savings are
achieved mainly by preventing unnecessary disease-oriented
investigations and treatments, as well as hospitalizations in
acute care hospitals and intensive care units.21–25 Value in
healthcare results from the balance between benefits and
costs. PC has demonstrated impact on both components of
value.
Academia (universities and colleges). According to
the UN Committee on Economic, Social and Cultural Rights
(CESCR), Member States are required to ensure universal
access to PC. This obligation includes the duty to ensure that
healthcare workers meet appropriate standards of education.4
Accordingly, the WHO urges Member States to integrate
basic PC training into all undergraduate medical and nursing
professional education.11 In other words, international law
stipulates that governments and universities of Member
States provide adequate training of healthcare workers pur-
suant to the principles laid out by the WHO.26
Studies also suggest that early and continuous student
exposure to PC education is associated with positive attitudes
and increased satisfaction toward PC among undergraduate
medical students.27 Studies also demonstrate undergraduate
nursing students’ belief that PC training should be an es-
sential component of their education, contributing favorably
to both their personal and professional development.4
Complete integration of PC courses into all undergraduate
curricula for future healthcare workers is both an obligation
under international law and an evidence-based educational
strategy.
Healthcare workers. In addition to requiring basic-level
PC training for all undergraduate medical and nursing pro-
fessional education, theWHO urges Member States to ensure
intermediate-level training to all healthcare workers who
routinely encounter patients with life-threatening illnesses
and to fully integrate PC into healthcare in every setting,
specifically highlighting community settings, and throughout
the course of advanced illnesses. Member States are also
required to provide specialist-level training to prepare
healthcare professionals who will engage in more than rou-
tine PC practice.4 This means that healthcare workers must
receive appropriate certification, acquiring competences that
are required by the proper standards of certification.
Specialist-level training is of particular importance in places
where the role of PC specialists has not yet been institu-
tionalized.
Hospitals and healthcare centers. Modern medical
science, unfortunately, based increasingly on technology, has
become so disease oriented as to neglect the human being.
Health-related suffering is often ignored.
Persistent attempts at treating the disease, even in the face
of futility of treatment, cause, in addition to physical, social,
and mental suffering, financial difficulties and spiritual dis-
tress. In his address to participants in the Plenary of the PAV
(Clementine Hall, March 5, 2015) Pope Francis said, ‘‘I
therefore welcome your scientific and cultural efforts to en-
sure that PC can reach all those who need it. I encourage
professionals and students to specialize in this type of as-
sistance, which has no less value on account of fact that it
does not save lives. PC recognizes something equally im-
portant, the value of person.’’15
The World Health Assembly in its landmark Resolution
of 20144 called upon all Member States to integrate PC in
Healthcare at all levels (primary, secondary, and tertiary)
across the continuum of care (from the time health-related
suffering starts until the death of the patient and continuing
thereafter in the form of bereavement support for the family).
PC associations. Patients who require PC often have
diverse and overlapping illnesses and may be staying at
home, in long-term care facilities, nursing homes, and hos-
pitals. Delivery of holistic services to patients requires mul-
tidisciplinary teams which may work in the national/public
health system, the church, or nongovernment sectors.4
These teams need to plan their interventions based on the
needs of the patient, whether adult or child, and the patient’s
family.28 To develop the skills and improve their knowledge,
the members of the multidisciplinary teams rely on guide-
lines and recommendations from PC associations and soci-
eties that often work with governments, other civil society
agencies, donors, and promoters of PC to set up functional
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Table 3. Highest Ranked PAL-LIFE Group Recommendations to Stakeholders for the Promotion
of Palliative Care and Suggestions for Implementation
Position Stakeholder and suggestions
1. Policy makers: Policy makers must recognize the societal and ethical value of palliative care and modify the existing
healthcare structures, policies, and outcome measures to ensure universal access to palliative care for all patients in
need. They must also take the steps to ensure an integrated health system, to allow a smooth flow of patients
between the different levels of care, so that patients with complex problems may be referred to secondary and
tertiary levels, as needed, and referred back to home care, if possible.
Suggestions for implementation:
 Involve national associations to advocate for palliative care
 Advocate with local policymakers for access to palliative care as a human right
 Link advocacy to other initiatives such as the movement of whole-person care, preventive medicine, and health
promotion
 Carryout a public awareness campaign focusing on needlessly suffering and the ethical responsibility of the
government.
 Include palliative care as a component of NCD national plans or strategies
2. Academia (universities and colleges): All academic institutions offering degrees in healthcare-related fields should
include mandatory palliative care courses as part of the undergraduate curricula.
Suggestions for implementation:
 Approve a national law where palliative care teaching is mandated
 Develop standard curricula on team-based interdisciplinary palliative care
 Palliative care curricula must combine theoretical and practical components integrated at the primary care level
 Teach palliative care by clinically experienced faculties who have academic appointments
 Funding for education programs should come from governments’ healthcare educational budgets.
 When palliative care is not taught, invite palliative care experts to deliver lectures on palliative care to create the
demand
 Adopt and implement the EAPC recommendations for the inclusion of palliative care in the undergraduate
curricula for medical and nursing schools and implement the Initiation for System Transformation project (ITES)
for countries throughout
Latin America
 Ensure training in the trainer courses, also in primary healthcare teaching.
3. Healthcare workers: Healthcare professionals working in palliative care should receive appropriate certification
while actively participating in continuing education to maintain the adequate competency levels
Suggestions for implementation:
 Reach out to the national boards of medicine and nursing and the Ministries of Health and education through
National Associations to advocate for the recognition of palliative care as a specialty.
 Establish a working group among members of the board of medicine and the board of nursing with palliative care
experts in the country to determine the minimum level of competencies, knowledge and skills in palliative care,
and years of dedication required to be recognized as palliative care professional.
 Standardize health professional education with basic and specialty certification programs according to each
country’s process of healthcare professional official certification
4. Hospitals and healthcare centers: Every hospital and healthcare center should ensure affordable access to palliative
care medicines included in the WHO Model List of Essential Medicines, particularly to immediate-release oral
morphine. It also should accept palliative care provision as a moral and ethical imperative.
Suggestions for implementation:
 Ensure training of all staff in the fundamentals of palliative care
 Define a palliative care integration strategy for the hospital or Health Center
 To establish a minimum dataset to monitor the quality of care in advance disease and end of life
5. Palliative care associations: Representatives of national associations should be effective advocates and work with
their governments in the process of implementing international policy framework, including Conventions,
Resolutions, and Declarations in their countries (i.e., UNGASS outcome document, Agenda 2030, WHA
Resolution).
Suggestions for implementation:
 Implement advocacy workshops with representatives of national associations to empower representatives of civil
society so that they adopt the skills to do effective advocacy campaigns and strategies.
 National associations have the power and legitimacy to request and demand from their governments the
implementation of the international policies and frameworks which call for the inclusion of palliative care in the
national policies and programs, the strengthening of NCD programs, and the adoption of the SDGs in the Agenda
2030.
 Work to set national standards in palliative care, including primary and specialist palliative education, and
training and work with both governmental and nongovernmental stakeholders to develop a national palliative
care strategy integrated into universal healthcare.
NCDs, noncommunicable diseases; SDGs, sustainable development goals; WHO, World Health Organization.
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capacity building, service delivery, and research networks.29
These build a system that can reach even the most disad-
vantaged communities not reached by conventional health-
care systems.30
Reflections for the advocacy of PC to second-line
stakeholders’ groups
International organizations. Recognizing that more
than 75% of the world has no access to PC services, WHO
Member States unanimously adoptedWHAResolution 67/19
in 2014. In 2015, UN Member States unanimously adopted
Agenda 2030 for Sustainable Development in 2015 with the
pledge to ‘‘leave no one behind.’’ Leaving no one behind
means that UNMember States and agencies must collaborate
to develop integrated, human rights based policies and pro-
cedures to realize their key public health outcomes. Human
rights based public health policies make integrated person-
centered services available to all citizens, migrants, and ref-
ugees of all ages in all settings: home, hostel or hospice, rural
or urban clinic, hospital, and long-term settings such as
nursing homes and prisons.3,16,31–38
Mass media. There is a misconception about PC both
among the general public and among healthcare professionals
that PC is synonymous with end-of-life care.39 PC is not just
for the dying. With this understanding comes an imperative
for patients to receive PC earlier in their disease trajectory.40
This requires a cultural shift that starts with physicians to the
general population.
Philanthropic organizations and charities. PC must
be integrated into national health systems around the world.
National governments have not provided adequate financing
to support PC development, and nongovernmental organi-
zations, professional organizations, foundations, faith-based
organizations, charities, charitable trusts, and development
agencies have played important roles in the development of
hospice and PC at the international and community levels,
providing both medical and social support.
With the potential for governments to provide universal
health coverage (UHC) and a basic package for PC, all donor
organizations must work with PC providers to develop in-
novative educational and social support systems.41–44
Pharmaceutical authorities. Morphine is recomm-
ended by the WHO as the first-line strong opioid for the
management of moderate-to-severe cancer pain in adults and
children.45–48 Although it is available in different formula-
tions,49 it is recommended that the availability of cheap
immediate-release oral morphine is a priority due to reasons
such as affordability and flexibility in use.50 Although other,
newer strong opioids should also be made available, avail-
ability of these newer opioids should not be considered as a
replacement to availability of morphine.
Table 4. Other PAL-LIFE Group Recommendations to Stakeholder Groups
for the Promotion of Palliative Care
No. Recommendations
6 To international organizations: International organizations should encourage WHO Member States to develop
policies and procedures to implement the WHA Resolution 67/19 as an integral part of their strategies and to
implement the Agenda 2030 for Sustainable Development Goals, paying specific attention to the needs of children
and older persons.
7 To the mass media: Mass media should be involved in creating a culture of understanding around advanced illness
and the role of palliative care throughout the life course and as a component of UHC.
8 To philanthropic organizations and charities: Individuals and organizations involved in palliative care must
engage, educate, and advocate for philanthropic organizations and charities to support palliative care development
and implementation of services.
9 To pharmaceutical authorities: Morphine (preferably immediate release oral formulation) is the preferred
medication for the treatment of moderate/severe cancer pain and palliative care and should be made available and
accessible. No government should approve modified-release morphine, transdermal fentanyl patches, or slow
release oxycodone without also guaranteeing widely available immediate-release oral morphine.
10 To patients and patient groups: Patients and patient groups could be of great help in developing and demanding a
health literacy campaign for all patients with PC needs and their families to increase the knowledge and
understanding of PC and its role in the decision-making process.
11 To spiritual care professionals: Religious institutions and spiritual care groups should work to include spiritual
care—including ongoing assessment of spiritual distress and spiritual well-being—integrated into guidelines of
care and as a component of routine palliative care provision.
12 To professional associations and societies other than Palliative Care: Nonpalliative care professional associations
and societies should encourage human rights organizations to consider existing declarations and to implement
strategies whose aim is advancing palliative care development worldwide within a human rights framework.
13 To pharmacists: Pharmacists should play an active role in palliative care teams by assessing the appropriateness of
the medicines prescribed to patients, by ensuring timely dispensation, by educating the team members about
pharmacological interactions, and by ensuring that patients and caregivers understand the prescribed regimen to
ensure adherence to treatment.
PC, palliative care; UHC, Universal Health Coverage.
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Patients and patient groups. Health illiteracy, even in
countries where PC is well developed, is an obstacle for early
integration of PC, which improves therapy.40 Mistakenly,
some patients may perceive that alleviating symptoms is a
way to hasten death.51 There is significant health illiteracy,
and patients and families are not aware that PC can be given
concurrently with active disease oriented therapies. Educa-
tion targeted to these groups can help to dispel the myths
about PC as hastening death or only a care approach for dying
patients.
Spiritual care professionals. The WHO has recog-
nized spiritual care as a required element of PC. Spiritual
distress (spiritual or existential suffering) needs to be ad-
dressed by all members of the team to provide the best
quality care for patients and families and to help relieve
suffering of patients and families. Several U.S. and inter-
national consensus conferences have developed definitions
and models for addressing spiritual distress in the clinical
setting.52
Religious leaders should advocate for the inclusion of in-
terprofessional spiritual care in PC and advocate for appro-
priate training of all clinicians in providing spiritual care to
patients and families, as well as developing, training, and
helping to sustain adequate staffing of healthcare chaplains in
all health settings.53,54
Non-PC professional associations and societies. Ac-
knowledgment of pain relief and PC as a human right have
been widely declared by many institutions and organiza-
tions.4,10,49,55,56
Pharmacists. PC patients often need to take multiple
medications simultaneously and, as a result, have an in-
creased risk of drug interactions and drug-related problems of
essential medicines for PC. Pharmacists have more knowl-
edge of medications and their effects than any other member
of the healthcare team and are, therefore, the best equipped to
detect possible problems and make the appropriate recom-
mendations.57,58
Discussion
This article presents the consensus of 13 PC experts from
around the world, in line with the PAL-LIFE objectives, on
what are considered the most important recommendations to
13 groups of stakeholders to help advance PC development.
Some of the recommendations are applicable to several
stakeholder groups (i.e., recommendation for pharmaceu-
tical authorities on morphine availability should also be
directed to lawmakers, administrators, pharmaceutical
manufacturers, dealers, and PC advocates or recommenda-
tion to universities should also be presented to healthcare
workers and educators).
Many of the items presented in this study require a coor-
dinated approach. Globally, a majority of patients die with
severe pain without having ever received a single dose of
morphine or other opioid analgesic. To address this tragic
situation, it is important to harmonize the need for increased
access to opioids for pain treatment, while taking into consid-
eration the abuse potential and adverse effects. This requires a
coordinated approach among policymakers, universities, phar-
macists, and professional associations so that safety measures
are put in place for the goals to be achieved.
The recommendations in this White Paper focus on crucial
issues. However, optimal situations may require more com-
prehensive and broader recommendations (i.e., the recom-
mendation for pharmaceutical authorities on morphine
availability should be accompanied by a statement clarifying
that more than one low priced opioid is needed since up to
80% of patients may need opioid rotation at some point, even
though only morphine is specifically recommended in this
study). The critical issue is that governments should take the
necessary steps to ensure access to PC medicines included on
the WHO Model List of Essential Medicines, including
morphine as the gold standard and all the others in the List.
Similarly, some recommendations may not capture the im-
portance of spiritual care that is equally important to the
physical and psychosocial domains. Spiritual, religious, and
existential concerns are also dimensions which require care
and should be addressed, registered, monitored, and managed
by the PC team.
One limitation of this article is that it is based on the con-
sensus of a small (13) group of PC experts and later approved
by the board of directors of the PAV. A larger group could
have probably resulted in additional stakeholder groups which
would have broadened the scope of this position article. For
these reasons, the group strongly recommends considering the
recommendations broadly, while taking into account the ad-
ditional 30 agreed-upon recommendations available on the
website of the PAV (www.academyforlife.va).
This white paper represents a position statement of the
PAV with regard to PC. Caring for the sick has been part of
the missionary activity of the Catholic Church since its in-
ception. The Church refers to PC as ‘‘a special form of dis-
interested charity. As such it should be encouraged’’
(Catechism of the Catholic Church, n. 2279). The Magister-
ium of the Catholic Church has intervened several times in
recent years to emphasize the dignity and preciousness of
each human being, even of those who are afflicted with se-
rious or terminal illnesses. Recently, Pope Francis described
PC as ‘‘an expression of the truly human attitude of taking care
of one another, especially of those who suffer. It is a testimony
that the human person is always precious, even if marked by
illness and old age. [.] Thus, I appreciate your scientific and
cultural commitment to ensuring that palliative care may reach
all those who need it. I encourage professionals and students to
specialize in this type of care that is no less valuable for the fact
that it ‘is not life-saving.’ PC accomplishes something equally
important: it values the person.’’15
The Christian movement, consistent with the teachings of
Jesus of caring for the destitute, the vulnerable, and the poor,
has developed and built large care networks which include
hospitals, clinics, and health centers throughout the world.
Faith-based hospitals and healthcare institutions, from local
clinics to tertiary research institutions, are all sites where PC
fits in as part of the concept of care and solidarity, as well as a
component of care within the health system. In many coun-
tries, regardless of the most prevalent professed faith, a sig-
nificant number of healthcare facilities are operated by the
Catholic Church and other Christian denominations. With
such a large network, the Church has the opportunity to lead a
major movement to relieve the suffering of millions of pa-
tients and their families.
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This White Paper may be used as a checklist for countries
or regions to identify and implement basic strategies to im-
prove the care for patients and families with PC needs. It can
also serve as the basis for development of a more compre-
hensive list of recommendations adapted to the institutions or
groups within each stakeholder group or specific geographi-
cal contexts. It will be undoubtedly useful for advocacy with
local governments, faith-based communities, and others.
In summary, this White Paper emphasizes the responsi-
bility of healthcare systems and stakeholders to recognize
access to pain relief and PC as a basic right of the person and
the family and the responsibility of all elements of the
healthcare system. For this, it is necessary to recognize health
as not only an absence of disease but also as physical, emo-
tional, social, and spiritual well-being, which can be optimized
only by making essential PC medicines available, govern-
ments integrating PC into their healthcare plans and UHC, and
developing public and professional education, as well as clear
frameworks for implementing this care to prevent needless
suffering. The support of faith-based and philanthropic orga-
nizations, nongovernmental and governmental actors, and
human rights organizations is needed to support PC integra-
tion. In short, a civil society response is needed.
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